Rath Ramashankar, Kharya Pradip, Mohanty Aroop, Koparkar Anil R, Dixit Anand M, Joshi Hari Shanker, Hada Vivek
Department of Community and Family Medicine, All India Institute of Medical sciences, Gorakhpur, Uttar Pradesh, India.
Department of Microbiology, All India Institute of Medical sciences, Gorakhpur, Uttar Pradesh, India.
Indian J Community Med. 2024 Dec;49(Suppl 2):S222-S227. doi: 10.4103/ijcm.ijcm_769_24. Epub 2024 Dec 30.
Antimicrobial resistance (AMR) is one of the important public health problems across the world. Low-middle-income countries are facing the problem more strongly than the high-income countries. AMR is likely to increase the cost of healthcare expenditure over the years. Over the years, various factors like unprecedented use of the antimicrobials in humans, animals, and plants or vegetations and over-the-counter sell of the antibiotics without prescription along with poor sanitation have led to the development and transfer of AMR across the various animal groups. To tackle the issue of the AMR in the country, the Government of India has launched the national program for containment of AMR in 2013 with six identified domains. A containment plan is currently being executed but yet to achieve the full extent as intended. Programmatic consideration aimed to address all the components of AMR development of AMR and its transmission across all levels of health care.
抗菌药物耐药性（AMR）是全球重要的公共卫生问题之一。中低收入国家比高收入国家面临这一问题的情况更为严峻。多年来，抗菌药物耐药性可能会增加医疗保健支出成本。多年来，诸如在人类、动物、植物或植被中前所未有的抗菌药物使用、无处方非处方药销售抗生素以及卫生条件差等各种因素，导致了抗菌药物耐药性在不同动物群体中的产生和传播。为解决该国的抗菌药物耐药性问题，印度政府于2013年启动了遏制抗菌药物耐药性的国家计划，确定了六个领域。目前正在执行一项遏制计划，但尚未达到预期的全部效果。规划性考虑旨在解决抗菌药物耐药性产生及其在各级医疗保健中传播的所有组成部分。
